Skip to content

targomed GmbH

German medical-scientific service provider specializing in ophthalmology clinical research, PMCF and medical writing.

Last updated September 27, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

targomed GmbH is a German service company that supports medical-scientific projects, with a pronounced specialization in ophthalmology. Based in Bruchsal, Germany, the firm was founded in 2010, although its team traces industry experience back to 1988 in the pharmaceutical and medical device sectors. It positions itself as an outsourcing partner for clinical research and medical affairs departments in the medical device and pharmaceutical industry, helping clients manage limited internal resources and uneven team workloads. The company's service portfolio covers the full life cycle of clinical studies with medical devices: strategic consulting, study concept development, documentation, coordination with investigative sites, sponsors and regulatory authorities, monitoring, data management and statistical analysis. A particular emphasis is placed on Post-Market Clinical Follow-Up (PMCF) strategies and post-market studies within and outside the European Medical Device Regulation (MDR) framework. targomed also offers proprietary digital tools, notably its EDC/data acquisition system targoDoc and a dedicated PMCF portal. Beyond operational study management, targomed provides content-oriented services such as statistical analyses, questionnaire design, complete EDC systems, study reports, MDR-required clinical evaluation reports, press releases and publication manuscripts. Its medical writing services include clinical study reports, regulatory documentation, scientific publications and conference contributions. The company states that its project managers all have a connection to ophthalmology, whether as optometrists, ophthalmic optics engineers or scientists with professional experience in the field. targomed describes its approach as flexible and modular, allowing clients to select which project areas they handle internally and which are outsourced. The firm emphasizes structured processes, deep scientific expertise and a commitment to quality, and it holds a DMSZ certificate for DIN EN ISO 9001:2015. Its regulatory familiarity spans MDR, MDCG, ISO, GCP, EUDAMED and 21 CFR Part 11. The company operates primarily in Germany and the broader European market, serving the medical device and pharmaceutical industry.

History

targomed GmbH was founded in 2010 in Germany, with its registered location in Bruchsal. Although the company itself is relatively young, its team brought together experience from the pharmaceutical and medical device industry dating back to 1988. This combination of a new corporate entity with long-standing industry expertise shaped the company's early identity as a specialized service provider rather than a manufacturer. From the outset, targomed focused on medical-scientific projects, particularly clinical studies involving medical devices. The company developed a modular service model that allows clients in clinical research and medical affairs departments to outsource selected tasks or entire projects. Over time, the firm built a strong specialization in ophthalmology, assembling a team of project managers with backgrounds as optometrists, ophthalmic optics engineers and scientists with professional experience in the field. As the regulatory landscape for medical devices evolved, especially with the introduction of the European Medical Device Regulation (MDR), targomed expanded its offerings to include Post-Market Clinical Follow-Up (PMCF) strategies and MDR-required clinical evaluation reports. The company also invested in digital infrastructure, developing its proprietary EDC/data acquisition system targoDoc and a dedicated PMCF portal to support data collection and study management. By the early 2020s, targomed had established a comprehensive portfolio spanning strategic consulting, study concept development, documentation, site and sponsor coordination, monitoring, data management, statistical analysis and medical writing. The company obtained a DMSZ certificate for DIN EN ISO 9001:2015, underscoring its commitment to quality management. It continues to operate as a privately held German company serving the medical device and pharmaceutical industry, primarily in Germany and Europe.

  • 2010

    targomed GmbH founded in Germany.

  • 1988

    Team experience in pharmaceutical and medical device industry begins (pre-founding).

Products and positioning

Specialized partner for medical-scientific projects with a strong focus on ophthalmology, offering flexible, modular outsourcing for clinical research and medical affairs.

  • targoDoc EDC system

    Proprietary electronic data capture and data acquisition system for clinical studies.

  • PMCF portal

    Dedicated portal for Post-Market Clinical Follow-Up activities.

Sources4 sources

Cite this profile: Cite the canonical profile. /brand-wiki/targomed-gmbh-germany · Editorial policy · How profiles are compiled